CVB homepage

Michael Reardon, MD, said monitoring under expansion would have made Acurate Neo2 non-inferior to current TAVR valves in the ACURATE IDE trial.

Michael Reardon, MD, co-principal investigator of the ACURATE IDE trial, discussed updated data on what may have impacted that study's findings.

From left to right: Sunita Ferns, MD; Mark Plunkett, MD; Harma Turbendian, MD. Images courtesy of OSF Healthcare.

A care team in Illinois has performed the first heart procedure of its kind on a two-year-old patient diagnosed with Brugada syndrome. 

Elderly

New research out of Denmark explored how undergoing TAVR may or may not influence the final year of a patient's life.

Following a plant-based diet can significantly lower a person’s risk of developing cardiovascular disease (CVD) or dying from cardiovascular causes, according to new research published in BMJ Nutrition, Prevention and Health.[1] The study’s authors emphasized that a person can still occasionally eat meat, fish or dairy products and still see substantial benefits—the key is to keep such things to a minimum and embrace fruits, vegetables, nuts, legumes, teas and coffees.

Experts say the DASH diet, designed to lower blood pressure and improve heart health, is fairly flexible and associated with several key benefits. 

Philips Biotel MCOT remote monitoring device on display at HRS 2023. Photo by Dave Fornell Long-term continuous monitoring (LTCM) wearable devices now make up 40% or more of the remote ECG monitoring market due to ease of use and collection or more data.

The American College of Cardiology published an expert consensus on practical approaches for arrhythmia monitoring after stroke to improve post-stroke care by identifying and managing atrial fibrillation.

Top videos on the Cardiovascular Business website about new cardiovascular trends and technologies in 2024.

A list of the most popular video interviews on Cardiovascular Business in 2024 based on reader analytics.